Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

434 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841.
Franko J, Shi Q, Goldman CD, Pockaj BA, Nelson GD, Goldberg RM, Pitot HC, Grothey A, Alberts SR, Sargent DJ. Franko J, et al. Among authors: goldberg rm. J Clin Oncol. 2012 Jan 20;30(3):263-7. doi: 10.1200/JCO.2011.37.1039. Epub 2011 Dec 12. J Clin Oncol. 2012. PMID: 22162570 Free PMC article. Clinical Trial.
Phase II trial of irinotecan in patients with metastatic colorectal carcinoma.
Pitot HC, Wender DB, O'Connell MJ, Schroeder G, Goldberg RM, Rubin J, Mailliard JA, Knost JA, Ghosh C, Kirschling RJ, Levitt R, Windschitl HE. Pitot HC, et al. Among authors: goldberg rm. J Clin Oncol. 1997 Aug;15(8):2910-9. doi: 10.1200/JCO.1997.15.8.2910. J Clin Oncol. 1997. PMID: 9256135 Clinical Trial.
Prospectively randomized North Central Cancer Treatment Group trial of intensive-course fluorouracil combined with the l-isomer of intravenous leucovorin, oral leucovorin, or intravenous leucovorin for the treatment of advanced colorectal cancer.
Goldberg RM, Hatfield AK, Kahn M, Sargent DJ, Knost JA, O'Connell MJ, Krook JE, Maillard JA, Wiesenfeld M, Schaefer PL, Tirona MT, Moertel CG. Goldberg RM, et al. J Clin Oncol. 1997 Nov;15(11):3320-9. doi: 10.1200/JCO.1997.15.11.3320. J Clin Oncol. 1997. PMID: 9363861 Clinical Trial.
Optimum doses of irinotecan.
Erlichman C, Goldberg RM, Pitot HC, O'Connell MJ. Erlichman C, et al. Among authors: goldberg rm. Lancet. 1999 Apr 10;353(9160):1275-6. doi: 10.1016/s0140-6736(05)75197-7. Lancet. 1999. PMID: 10217115 No abstract available.
Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers.
Halling KC, French AJ, McDonnell SK, Burgart LJ, Schaid DJ, Peterson BJ, Moon-Tasson L, Mahoney MR, Sargent DJ, O'Connell MJ, Witzig TE, Farr GH Jr, Goldberg RM, Thibodeau SN. Halling KC, et al. Among authors: goldberg rm. J Natl Cancer Inst. 1999 Aug 4;91(15):1295-303. doi: 10.1093/jnci/91.15.1295. J Natl Cancer Inst. 1999. PMID: 10433618
Phase I dose-finding and pharmacokinetic trial of irinotecan hydrochloride (CPT-11) using a once-every-three-week dosing schedule for patients with advanced solid tumor malignancy.
Pitot HC, Goldberg RM, Reid JM, Sloan JA, Skaff PA, Erlichman C, Rubin J, Burch PA, Adjei AA, Alberts SA, Schaaf LJ, Elfring G, Miller LL. Pitot HC, et al. Among authors: goldberg rm. Clin Cancer Res. 2000 Jun;6(6):2236-44. Clin Cancer Res. 2000. PMID: 10873073 Clinical Trial.
434 results